{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:24:01Z","timestamp":1788168241899,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.lanwpc.2026.101957","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:37:39Z","timestamp":1787009859000},"page":"101957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Infection-driven cancers in Asia: implications from epidemiological transitions"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0214-3649","authenticated-orcid":false,"given":"Yingsong","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1276-2398","authenticated-orcid":false,"given":"Manami","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lanwpc.2026.101957_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41435-022-00192-6","article-title":"Gene-environment interactions and their impact on human health","volume":"24","author":"Virolainen","year":"2023","journal-title":"Genes Immun"},{"issue":"10512","key":"10.1016\/j.lanwpc.2026.101957_bib2","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(25)01635-6","article-title":"The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","year":"2025","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.lanwpc.2026.101957_bib3","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.lanwpc.2026.101957_bib4","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s41591-026-04219-7","article-title":"Global and regional cancer burden attributable to modifiable risk factors to inform prevention","volume":"32","author":"Fink","year":"2026","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.lanwpc.2026.101957_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens--Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.lanwpc.2026.101957_bib6","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.lanwpc.2026.101957_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.35772\/ghmo.2021.01016","article-title":"Burden of cancer attributable to infection in Japan in 2015","volume":"1","author":"Lin","year":"2021","journal-title":"GHM Open"},{"issue":"26","key":"10.1016\/j.lanwpc.2026.101957_bib8","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2025.40.e143","article-title":"Preventable cancers caused by infection in Korea from 2015 to 2030","volume":"40","author":"Moon","year":"2025","journal-title":"J Korean Med Sci"},{"issue":"4","key":"10.1016\/j.lanwpc.2026.101957_bib9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ijc.70114","article-title":"Over one-third of cancer cases and two-fifths of cancer deaths in southern China are preventable: insights from the latest representative population-based cancer registry data and risk factor survey","volume":"158","author":"Wen","year":"2026","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101957_bib10","article-title":"Changing trends in the prevalence of H. pylori infection in Japan (1908-2003): a systematic review and meta-regression analysis of 170,752 individuals","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.lanwpc.2026.101957_bib11","article-title":"Towards elimination of cervical cancer - human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries","volume":"39","author":"Ong","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101957_bib12","first-page":"531","article-title":"The occurrence of lung cancer in man","volume":"9","author":"Levin","year":"1953","journal-title":"Acta Unio Int Contra Cancrum"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101957_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40471-016-0085-5","article-title":"Population attributable and preventable fractions: cancer risk factor surveillance, and cancer policy projection","volume":"3","author":"Shield","year":"2016","journal-title":"Curr Epidemiol Rep"},{"issue":"5","key":"10.1016\/j.lanwpc.2026.101957_bib14","first-page":"405","article-title":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019","volume":"74","author":"Islami","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10.1016\/j.lanwpc.2026.101957_bib15","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41416-018-0029-6","article-title":"The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015","volume":"118","author":"Brown","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lanwpc.2026.101957_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejca.2018.09.009","article-title":"Cancers related to lifestyle and environmental factors in France in 2015","volume":"105","author":"Soerjomataram","year":"2018","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.lanwpc.2026.101957_bib17","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/annonc\/mdr437","article-title":"Attributable causes of cancer in Japan in 2005--systematic assessment to estimate current burden of cancer attributable to known preventable risk factors in Japan","volume":"23","author":"Inoue","year":"2012","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.lanwpc.2026.101957_bib18","first-page":"1153","article-title":"Estimation of cancer cases and deaths attributable to infection in China","volume":"22","author":"Xiang","year":"2011","journal-title":"Cancer Causes Control"},{"issue":"6","key":"10.1016\/j.lanwpc.2026.101957_bib19","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1093\/annonc\/mdq592","article-title":"Population attributable fraction of infection-related cancers in Korea","volume":"22","author":"Shin","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lanwpc.2026.101957_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1200\/JGO.19.00239","article-title":"Attributable causes of cancer in Vietnam","volume":"6","author":"Nguyen","year":"2020","journal-title":"JCO Glob Oncol"},{"issue":"10","key":"10.1016\/j.lanwpc.2026.101957_bib21","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1093\/annonc\/mdx342","article-title":"Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013","volume":"28","author":"Islami","year":"2017","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101957_bib22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/j.gastro.2015.09.004","article-title":"Pathobiology of Helicobacter pylori-Induced Gastric Cancer","volume":"150","author":"Amieva","year":"2016","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.lanwpc.2026.101957_bib23","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/s10038-021-00960-8","article-title":"Lifestyles, genetics, and future perspectives on gastric cancer in east Asian populations","volume":"66","author":"Katoh","year":"2021","journal-title":"J Hum Genet"},{"issue":"13","key":"10.1016\/j.lanwpc.2026.101957_bib24","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa2211807","article-title":"Helicobacter pylori, homologous-recombination genes, and gastric cancer","volume":"388","author":"Usui","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.lanwpc.2026.101957_bib25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","article-title":"Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022","volume":"166","author":"Chen","year":"2024","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.lanwpc.2026.101957_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/apt.12380","article-title":"Review article: historic changes of Helicobacter pylori-associated diseases","volume":"38","author":"Sonnenberg","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.lanwpc.2026.101957_bib27","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jiac.2019.02.016","article-title":"Rapidly decreasing prevalence of Helicobacter pylori among Japanese children and adolescents","volume":"25","author":"Miyamoto","year":"2019","journal-title":"J Infect Chemother"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101957_bib28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/jgh.15751","article-title":"Prevalence of Helicobacter pylori infection in China: a systematic review and meta-analysis","volume":"37","author":"Ren","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.lanwpc.2026.101957_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204762","article-title":"Trends in the seroprevalence of Helicobacter pylori infection and its putative eradication rate over 18 years in Korea: a cross-sectional nationwide multicenter study","volume":"13","author":"Lim","year":"2018","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.lanwpc.2026.101957_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10120-016-0658-5","article-title":"Changing epidemiology of Helicobacter pylori in Japan","volume":"20","author":"Inoue","year":"2017","journal-title":"Gastric Cancer"},{"issue":"6","key":"10.1016\/j.lanwpc.2026.101957_bib31","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bpg.2014.10.003","article-title":"The fight against gastric cancer - the IARC Working Group report","volume":"28","author":"Herrero","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.lanwpc.2026.101957_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12415","article-title":"Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan","volume":"22","author":"Tsuda","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.lanwpc.2026.101957_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/5584_2019_361","article-title":"Helicobacter pylori infection in children and adolescents","volume":"1149","author":"Okuda","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101957_bib34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/den.14063","article-title":"Endoscopic screening for gastric cancer in Japan: current status and future perspectives","volume":"34","author":"Mabe","year":"2022","journal-title":"Dig Endosc"},{"issue":"7","key":"10.1016\/j.lanwpc.2026.101957_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2183\/pjab.87.405","article-title":"Gastric cancer screening by combined assay for serum anti-helicobacter pylori IgG antibody and serum pepsinogen levels - \"ABC method\"","volume":"87","author":"Miki","year":"2011","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"12","key":"10.1016\/j.lanwpc.2026.101957_bib36","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2169\/internalmedicine.3521-19","article-title":"Usefulness and limitations of a serum screening system to predict the risk of gastric cancer","volume":"59","author":"Kishino","year":"2020","journal-title":"Intern Med"},{"issue":"6","key":"10.1016\/j.lanwpc.2026.101957_bib37","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1053\/j.gastro.2017.01.029","article-title":"Effectiveness of the Korean national cancer screening program in reducing gastric cancer mortality","volume":"152","author":"Jun","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lanwpc.2026.101957_bib38","series-title":"Population-based Helicobacter pylori screen-and-treat Strategies for gastric cancer prevention: guidance on implementation","year":"2025"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101957_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/hel.70052","article-title":"The increasing trend of the generational Helicobacter pylori-na\u00efve prevalence among Japanese individuals born between 1925 and 2015: a systematic review and meta-regression analysis","volume":"30","author":"Ishibashi","year":"2025","journal-title":"Helicobacter"},{"issue":"50","key":"10.1016\/j.lanwpc.2026.101957_bib40","first-page":"645","article-title":"Human papillomavirus (HPV) vaccines: WHO position paper (2022 update)","volume":"97","year":"2022","journal-title":"Wkly Epidemiol Rec"},{"issue":"14","key":"10.1016\/j.lanwpc.2026.101957_bib41","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanwpc.2026.101957_bib42","series-title":"Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem","year":"2020"},{"key":"10.1016\/j.lanwpc.2026.101957_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103290","article-title":"Global HPV vaccination programs and coverage rates: a systematic review","volume":"84","author":"Han","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"4","key":"10.1016\/j.lanwpc.2026.101957_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(23)00118-3","article-title":"India rolls out HPV vaccination","volume":"24","author":"Burki","year":"2023","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.lanwpc.2026.101957_bib47","first-page":"1275","article-title":"The behavioural and social drivers of HPV vaccination among parents and young people in Indonesia: a scoping review","volume":"36","author":"Athifa","year":"2025","journal-title":"Cancer Causes Control"},{"issue":"12","key":"10.1016\/j.lanwpc.2026.101957_bib48","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/S1470-2045(18)30573-4","article-title":"Beyond resumption of the Japanese Government's recommendation of the HPV vaccine","volume":"19","author":"Ueda","year":"2018","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101957_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.6862","article-title":"A comprehensive narrative review of challenges and facilitators in the implementation of various HPV vaccination program worldwide","volume":"13","author":"Aggarwal","year":"2024","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101957_bib51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12916-023-02988-3","article-title":"Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis","volume":"21","author":"Prem","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.lanwpc.2026.101957_bib52","article-title":"Long-term efficacy and immunopersistence of an Escherichia coli-produced HPV-16\/18 bivalent vaccine: an observational extension study following a randomised, double-blind Phase III clinical trial cohort","volume":"61","author":"Zhao","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"issue":"Suppl 1","key":"10.1016\/j.lanwpc.2026.101957_bib53","doi-asserted-by":"crossref","first-page":"A94","DOI":"10.1016\/j.vaccine.2021.12.066","article-title":"Integration of other services with human papillomavirus vaccination; lessons from earlier in the life course highlight the need for new policy and implementation evidence","volume":"40","author":"Morgan","year":"2022","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.lanwpc.2026.101957_bib54","doi-asserted-by":"crossref","DOI":"10.2196\/23350","article-title":"Digital health strategies for cervical cancer control in Low- and middle-income countries: systematic review of current implementations and gaps in research","volume":"23","author":"Rossman","year":"2021","journal-title":"J Med Internet Res"},{"issue":"7","key":"10.1016\/j.lanwpc.2026.101957_bib55","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1080\/21645515.2020.1756670","article-title":"Multidimensional social and cultural norms influencing HPV vaccine hesitancy in Asia","volume":"16","author":"Wong","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"10.1016\/j.lanwpc.2026.101957_bib56","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/liv.15131","article-title":"Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: results from modelling and global reporting","volume":"42","author":"Le","year":"2022","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.lanwpc.2026.101957_bib59","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/bjc.1986.269","article-title":"Mortality of hepatoma and cirrhosis of liver in Taiwan","volume":"54","author":"Lin","year":"1986","journal-title":"Br J Cancer"},{"issue":"26","key":"10.1016\/j.lanwpc.2026.101957_bib60","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children","volume":"336","author":"Chang","year":"1997","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.lanwpc.2026.101957_bib61","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1111\/liv.15959","article-title":"Survey of hepatitis B virus infection status after 35 years of universal vaccination implementation in Taiwan","volume":"44","author":"Chang","year":"2024","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.lanwpc.2026.101957_bib62","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41575-024-00967-4","article-title":"Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions","volume":"21","author":"Mak","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.lanwpc.2026.101957_bib63","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metab"},{"issue":"Suppl 1","key":"10.1016\/j.lanwpc.2026.101957_bib64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000333210","article-title":"Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area","volume":"84","author":"Cho","year":"2011","journal-title":"Digestion"},{"issue":"4","key":"10.1016\/j.lanwpc.2026.101957_bib65","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00535-018-1532-5","article-title":"A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update","volume":"54","author":"Tateishi","year":"2019","journal-title":"J Gastroenterol"},{"issue":"12","key":"10.1016\/j.lanwpc.2026.101957_bib66","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc.2016.92","article-title":"Epstein-Barr virus: more than 50 years old and still providing surprises","volume":"16","author":"Young","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.lanwpc.2026.101957_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/bjbs.2025.15902","article-title":"Nasopharyngeal carcinoma in Southeast Asia: current landscape and future priorities","volume":"82","author":"Chan","year":"2025","journal-title":"Br J Biomed Sci"},{"key":"10.1016\/j.lanwpc.2026.101957_bib68","doi-asserted-by":"crossref","DOI":"10.2196\/49968","article-title":"Nasopharyngeal cancer incidence and mortality in 185 countries in 2020 and the projected burden in 2040: population-based global epidemiological profiling","volume":"9","author":"Zhang","year":"2023","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.lanwpc.2026.101957_bib69","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/ijc.10894","article-title":"Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20 year period (1980\u201399): an encouraging reduction in both incidence and mortality","volume":"103","author":"Lee","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lanwpc.2026.101957_bib70","doi-asserted-by":"crossref","first-page":"9899","DOI":"10.7314\/APJCP.2014.15.22.9899","article-title":"Time trends of nasopharyngeal carcinoma in urban Guangzhou over a 12 year period (2000\u20132011): declines in both incidence and mortality","volume":"15","author":"Li","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101957_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41571-025-01079-x","article-title":"Achieving control of nasopharyngeal carcinoma: the role of Epstein-Barr virus-based screening and vaccines","volume":"23","author":"Lam","year":"2026","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.lanwpc.2026.101957_bib72","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001549","article-title":"A global phylogenetic analysis of Japanese tonsil-derived Epstein-Barr virus strains using viral whole-genome cloning and long-read sequencing","volume":"102","author":"Yajima","year":"2021","journal-title":"J Gen Virol"},{"issue":"10192","key":"10.1016\/j.lanwpc.2026.101957_bib73","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.lanwpc.2026.101957_bib74","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1055-9965.EPI-06-0353","article-title":"The enigmatic epidemiology of nasopharyngeal carcinoma","volume":"15","author":"Chang","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.lanwpc.2026.101957_bib75","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1158\/1055-9965.EPI-20-1702","article-title":"The evolving epidemiology of nasopharyngeal carcinoma","volume":"30","author":"Chang","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"10.1016\/j.lanwpc.2026.101957_bib76","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ng.601","article-title":"A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci","volume":"42","author":"Bei","year":"2010","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.lanwpc.2026.101957_bib77","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/s41588-019-0436-5","article-title":"Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma","volume":"51","author":"Xu","year":"2019","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101957_bib78","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1038\/s41467-022-29570-4","article-title":"A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening","volume":"13","author":"He","year":"2022","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.lanwpc.2026.101957_bib79","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa2301496","article-title":"Anti-Epstein-Barr virus BNLF2b for mass screening for nasopharyngeal cancer","volume":"389","author":"Li","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.lanwpc.2026.101957_bib80","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.mehy.2012.09.003","article-title":"Why are East Asians more susceptible to several infection-associated cancers (carcinomas of the nasopharynx, stomach, liver, adenocarcinoma of the lung, nasal NK\/T-cell lymphomas)?","volume":"79","author":"Wee","year":"2012","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.lanwpc.2026.101957_bib81","series-title":"Infection and Cancer: Bi-Directional Interactions","author":"Shurin","year":"2015"},{"key":"10.1016\/j.lanwpc.2026.101957_bib82","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.bpg.2015.09.013","article-title":"Screening of gastric cancer in Asia","volume":"29","author":"Sugano","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.lanwpc.2026.101957_bib83","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3350\/cmh.2023.0099","article-title":"Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: an Asian perspective comparison","volume":"29","author":"Cho","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"10.1016\/j.lanwpc.2026.101957_bib84","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2016.08.038","article-title":"Pioneering a global cure for chronic hepatitis C virus infection","volume":"167","author":"Vilarinho","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.lanwpc.2026.101957_bib85","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","article-title":"Mutational signature in colorectal cancer caused by genotoxic pks+E. coli","volume":"580","author":"Pleguezuelos-Manzano","year":"2020","journal-title":"Nature"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606526001616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606526001616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:08:34Z","timestamp":1788167314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606526001616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":80,"alternative-id":["S2666606526001616"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101957","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infection-driven cancers in Asia: implications from epidemiological transitions","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101900","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101958","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2026.101852","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101957"}}